T1	intervention 52 61	Celecoxib
T2	condition 84 97	Skin Toxicity
T4	total-participants 552 557	Sixty
T5	control 635 642	placebo
T10	outcome 1161 1195	frequency of increased breast size
T11	outcome 1363 1378	skin dermatitis
T9	outcome 1078 1112	radiation-induced itching and pain
T12	eligibility 523 550	patients with breast cancer
T3	outcome 1451 1461	dermatitis
T6	outcome 1517 1533	itching and pain
